Lista de obras -

A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells

artículo científico publicado en 2016

A general path for large-scale solubilization of cellular proteins: from membrane receptors to multiprotein complexes.

artículo científico publicado en 2012

An episodic ataxia type-1 mutation in the S1 segment sensitises the hKv1.1 potassium channel to extracellular Zn2+.

artículo científico publicado en 2004

Antioxidant Bioprospecting in Microalgae: Characterisation of the Potential of Two Marine Heterokonts from Irish Waters

scientific article published on 20 November 2020

Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production.

artículo científico publicado en 2006

COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.

artículo científico publicado en 2011

Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells

artículo científico publicado en 2015

Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1.

artículo científico publicado en 2006

Functional characterization of an episodic ataxia type-1 mutation occurring in the S1 segment of hKv1.1 channels

artículo científico publicado en 2003

GSK-3 in liver diseases: Friend or foe?

artículo científico publicado en 2020

Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors.

artículo científico publicado en 2004

Molecular mechanisms of sorafenib action in liver cancer cells.

artículo científico publicado en 2012

New landscapes and horizons in hepatocellular carcinoma therapy

scientific article published on 04 February 2020

Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells

artículo científico publicado en 2010

Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.

artículo científico publicado en 2013

Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation

artículo científico publicado en 2017

Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma

artículo científico publicado en 2017

Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.

artículo científico publicado en 2007

Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells

artículo científico publicado en 2018

Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth.

artículo científico publicado en 2009

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

scientific article published on 04 November 2019

Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins).

artículo científico publicado en 2002

Synthetic peptide-labelled micelles for active targeting of cells overexpressing EGF receptors

artículo científico publicado en 2019

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon ⬇️

artículo científico publicado el 1 de marzo de 2012

Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma

scientific article published on 24 December 2018

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

artículo científico publicado en 2020

The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells

artículo científico publicado en 2006

WNT5A inhibits hepatocyte proliferation and concludes β-catenin signaling in liver regeneration

artículo científico publicado en 2015

Lista de obras de

A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells

A general path for large-scale solubilization of cellular proteins: from membrane receptors to multiprotein complexes.

An episodic ataxia type-1 mutation in the S1 segment sensitises the hKv1.1 potassium channel to extracellular Zn2+.

Antioxidant Bioprospecting in Microalgae: Characterisation of the Potential of Two Marine Heterokonts from Irish Waters

Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production.

COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.

Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells

Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1.

Functional characterization of an episodic ataxia type-1 mutation occurring in the S1 segment of hKv1.1 channels

GSK-3 in liver diseases: Friend or foe?

Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors.

Molecular mechanisms of sorafenib action in liver cancer cells.

New landscapes and horizons in hepatocellular carcinoma therapy

Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells

Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.

Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation

Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma

Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.

Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells

Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth.

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins).

Synthetic peptide-labelled micelles for active targeting of cells overexpressing EGF receptors

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon ⬇️

Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells

WNT5A inhibits hepatocyte proliferation and concludes β-catenin signaling in liver regeneration